The MAI-FOIE Cohort
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10+
SponsorNantes University Hospital
About this trial
The MAI-FOIE cohort will be a French multicenter cohort with the development of a biobank including patients with autoimmune, metabolic and medicated liver diseases
Eligibility criteria
Qualifiers
age≥10 years old
weight≥25kg
ALT>2N or IgG>1.1N
Presence of autoantibodies : ANA (antinuclear), ML (anti-smooth muscle), SLA (anti-soluble liver antigen), LKM1 (anti-endoplasmic reticulum), LC1 (anti-liver cytosol)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
800 Participants
are grouped into 2 trial groupsSponsors and collaborators
Nantes University Hospital
Lead sponsor
Direction Générale de l'Offre de Soins
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
National Cancer Institute, France
Collaborator
Association Française pour l'Etude du Foie (AFEF)
Collaborator
ALBI
Collaborator
FILFOIE
Collaborator
GIRCIGO
Collaborator
CR2TI-U1064
Collaborator
HEPATIM-GO network
Collaborator
CIC IMAD
Collaborator
Source ClinicalTrials.gov